329 related articles for article (PubMed ID: 17381798)
21. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
[TBL] [Abstract][Full Text] [Related]
22. Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
Sperr WR; El-Samahi A; Kundi M; Girschikofsky M; Winkler S; Lutz D; Endler G; Rumpold H; Agis H; Sillaber C; Jäger U; Valent P
Eur J Clin Invest; 2009 Oct; 39(10):914-23. PubMed ID: 19522836
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
[TBL] [Abstract][Full Text] [Related]
24. MITF-CM, a newly identified isoform of microphthalmia-associated transcription factor, is expressed in cultured mast cells.
Shiohara M; Shigemura T; Suzuki T; Tanaka M; Morii E; Ohtsu H; Shibahara S; Koike K
Int J Lab Hematol; 2009 Apr; 31(2):215-26. PubMed ID: 18284417
[TBL] [Abstract][Full Text] [Related]
25. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
[TBL] [Abstract][Full Text] [Related]
26. Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.
Gutiérrez-González E; Ginarte M; Toribio J
Dermatol Online J; 2011 Nov; 17(11):15. PubMed ID: 22136871
[TBL] [Abstract][Full Text] [Related]
27. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
28. Stillborn or liveborn? Comparing umbilical cord immunohistochemical expression of vitality markers (tryptase, alpha(1)-antichymotrypsin and CD68) by quantitative analysis and confocal laser scanning microscopy.
Neri M; D'Errico S; Fiore C; Pomara C; Rabozzi R; Riezzo I; Turillazzi E; Greco P; Fineschi V
Pathol Res Pract; 2009; 205(8):534-41. PubMed ID: 19250758
[TBL] [Abstract][Full Text] [Related]
29. An updated approach to the diagnosis of myeloid leukemia cutis.
Cronin DM; George TI; Sundram UN
Am J Clin Pathol; 2009 Jul; 132(1):101-10. PubMed ID: 19864240
[TBL] [Abstract][Full Text] [Related]
30. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
[TBL] [Abstract][Full Text] [Related]
31. Involvement of MITF-A, an alternative isoform of mi transcription factor, on the expression of tryptase gene in human mast cells.
Lee SH; Lee JH; Lee JH; Kim DK
Exp Mol Med; 2010 May; 42(5):366-75. PubMed ID: 20513998
[TBL] [Abstract][Full Text] [Related]
32. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
33. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells.
Thienemann F; Henz BM; Babina M
Arch Dermatol Res; 2004 Aug; 296(3):134-8. PubMed ID: 15322832
[TBL] [Abstract][Full Text] [Related]
34. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
Cronin DM; George TI; Reichard KK; Sundram UN
Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
[TBL] [Abstract][Full Text] [Related]
36. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
Kupfer SS; Hart J; Mohanty SR
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
[TBL] [Abstract][Full Text] [Related]
37. Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.
Horny HP; Sotlar K; Reiter A; Valent P
Expert Rev Hematol; 2014 Aug; 7(4):431-7. PubMed ID: 25025369
[TBL] [Abstract][Full Text] [Related]
38. Microphthalmia transcription factor isoforms in mast cells and the heart.
Tshori S; Sonnenblick A; Yannay-Cohen N; Kay G; Nechushtan H; Razin E
Mol Cell Biol; 2007 Jun; 27(11):3911-9. PubMed ID: 17438132
[TBL] [Abstract][Full Text] [Related]
39. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
[TBL] [Abstract][Full Text] [Related]
40. State of the art in myeloid sarcoma.
Klco JM; Welch JS; Nguyen TT; Hurley MY; Kreisel FH; Hassan A; Lind AC; Frater JL
Int J Lab Hematol; 2011 Dec; 33(6):555-65. PubMed ID: 21883967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
